Hoth Therapeutics (NASDAQ: $HOTH) is gaining fresh momentum in the microcap biotech space following its announcement of a key expansion in the CLEER-001 Phase 2a […]
Tag: HOTH
Hoth Therapeutics (NASDAQ: HOTH) Unveils Plan To Submit HT-001 Expanded Access Application Amid Double Digit Growth in The Past Week: What To Know About Hoth
Hoth Therapeutics (NASDAQ: $HOTH), a clinical-stage biopharmaceutical working to develop innovative therapies, announced on Monday, March 10, 2025, that it planned to submit an Expanded […]